How to evaluate antiarrhythmic agents in an essentially asymptomatic population. Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 1994
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Anti-Arrhythmia Agents (MeSH)
- Atrial Fibrillation (MeSH)
- Canada (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Evaluation (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Myocardial Infarction (MeSH)
- Ventricular Fibrillation (MeSH)
- Wolff-Parkinson-White Syndrome (MeSH)
published in
- Canadian Journal of Cardiology Journal